ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 66.60
-1.80 (-2.63%)
Feb 11, 2026, 1:59 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 4.19 billion as of February 10, 2026. Its market cap has increased by 178.61% in one year.
Market Cap
4.19B
Enterprise Value
3.75B
Revenue
36.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
66.60
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 1.38B to 4.19B, an increase of 203.40%. That is a compound annual growth rate of 27.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 4.19B | 3.64% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.98M | -31.96% |
| Jul 27, 2021 | 1.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senhwa Biosciences | 4.87B |
| AnnJi Pharmaceutical | 4.69B |
| BioGend Therapeutics | 4.53B |
| Medigen Biotechnology | 4.40B |
| Formosa Pharmaceuticals | 4.15B |
| Energenesis Biomedical CO.,LTD. | 4.12B |
| BRIM Biotechnology | 3.90B |
| Intech Biopharm | 3.82B |